Structure |
Chemical Name |
CAS |
MF |
 |
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
 |
(3R,4R,5R)-Oseltamivir |
|
|
 |
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
![(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione](/CAS/20211123/GIF/2300966-23-6.gif) |
(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
2300966-23-6 |
C16H14ClFN4O2 |
 |
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
 |
2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine |
130676-57-2 |
C12H12N4O4 |
 |
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
 |
2-(2-pyridyl)isothiourea N-oxide hydrochloride |
2770-93-6 |
C6H8ClN3OS |
 |
disodium tetrabromophthalate |
25357-79-3 |
C8Br4Na2O4 |
 |
5-Pyrimidinecarboxylic acid, 2-chloro-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847463-39-1 |
C17H16ClN3O2 |
 |
cytidylyl(5'->3')adenosine |
4833-63-0 |
C19H25N8O11P |
 |
(S)-2-Amino-5-methoxytetralin Hydrochloride |
58349-17-0 |
C11H15NO.HCl |
 |
2-Bromo-3',4'-(methylenedioxy)propiophenone |
52190-28-0 |
C10H9BrO3 |
 |
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
 |
1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) |
109591-12-0 |
C17H41N2O+ |
 |
11-Prostaglandin F2a |
|
|
 |
4-Formyl-2-isopropylthiazole |
133047-46-8 |
C7H9NOS |
 |
L-Cephalexin |
34632-04-7 |
C16H17N3O4S |
 |
3,4-Diiodopyrazole |
6645-70-1 |
C3H2I2N2 |
![4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid](/CAS/GIF/641569-94-0.gif) |
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 |
C17H14N4O2 |
 |
4-Bromopyrazole |
2075-45-8 |
C3H3BrN2 |
 |
(Ac)Phe-Lys(Alloc)-PABC-PNP |
|
C??H??N?O?? |
 |
2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile |
1187595-85-2 |
C7H10N2O2S |
 |
4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
170985-61-2 |
C37H42F2N8O4 |
 |
Velpatasvir intermediate |
1378391-45-7 |
C44H53N7O7 |
 |
Br-PEG1-NHBoc |
164332-88-1 |
C9H18BrNO3 |
![(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride](/CAS/20180703/GIF/1701403-10-2.gif) |
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
![(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid](/CAS/20180703/GIF/1616342-45-0.gif) |
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid |
1616342-45-0 |
C15H16N2O6 |
 |
Coumarin 102 |
41267-76-9 |
C16H17NO2 |
 |
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
![(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate](/CAS/20200331/GIF/1187595-90-9.gif) |
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
 |
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
![(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid](/CAS/20200401/GIF/927820-48-2.gif) |
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
 |
Rimonabant hydrochloride |
158681-13-1 |
C22H21Cl3N4O.ClH |
 |
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene |
461432-23-5 |
C15H14BrClO |
 |
3-isobutylglutaric anhydride |
185815-59-2 |
C9H14O3 |
 |
7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID |
80370-59-8 |
C13H12N2O5S2 |
![2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-](/CAS/GIF/852148-49-3.gif) |
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
![8-bromo-1,4-dioxaspiro[4.5]decane](/CAS/20150408/GIF/68278-51-3.gif) |
8-bromo-1,4-dioxaspiro[4.5]decane |
68278-51-3 |
C8H13BrO2 |
 |
Retigabine Dihydrochloride |
150812-13-8 |
C16H20Cl2FN3O2 |
 |
QUINUCLIDINE |
100-76-5 |
C7H13N |
 |
6-nitrocoumarin |
2725-81-7 |
C9H5NO4 |
 |
(S)-1-Amino-3-chloro-2-propanol hydrochloride |
34839-13-9 |
C3H9Cl2NO |
 |
9β,11β-Epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione |
981-34-0 |
C22H28O5 |
 |
Ethyl 3-(N,N-dimethylamino)acrylate |
1117-37-9 |
C7H13NO2 |
 |
3,4-Dichloro-6-(trifluoromethyl)toluene |
74483-51-5 |
C8H5Cl2F3 |
![BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE](/CAS/GIF/518047-98-8.gif) |
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
![4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](/CAS/GIF/941685-27-4.gif) |
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine |
941685-27-4 |
C15H21N5OSi |
 |
4,7-Bis(2-bromo-5-thienyl)-2,1,3-benzothiadiazole |
288071-87-4 |
C14H6Br2N2S3 |
 |
(1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
895152-66-6 |
C16H19NO |
![Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]-](/CAS/20180713/GIF/61848-66-6.gif) |
Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- |
61848-66-6 |
C6H12Cl2N2Pt |
 |
20-HYDROXY PROSTAGLANDIN E2 |
57930-95-7 |
C20H32O6 |
![2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine](/CAS2/GIF/181210-18-4.gif) |
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
 |
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
 |
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
 |
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
 |
N-ForMyl- |
104872-27-7 |
C29H53NO5 |
![3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine](/CAS/GIF/1022150-12-4.gif) |
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
 |
4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline |
190728-25-7 |
C17H16N2O3 |
 |
McMMAE |
863971-24-8 |
C49H78N6O10 |
 |
2-Amino-4-bromo-3-fluorobenzoic acid |
1416013-62-1 |
C7H5BrFNO2 |
 |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
 |
Neratinib Maleate |
915942-22-2 |
C34H33ClN6O7 |
 |
Oclacitinib Maleate(PF-03394197) |
1208319-27-0 |
C19H27N5O6S |
 |
4,6,7-trihydroxycoumarin |
22649-24-7 |
C9H6O5 |
 |
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
 |
Methyl 4-isopropyl-3,5-dimethoxybenzoate |
344396-17-4 |
C13H18O4 |
![(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester](/CAS/20180703/GIF/1420478-88-1.gif) |
(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester |
1420478-88-1 |
C18H18BrN5O2 |
 |
(9H-fluoren-9-yl)methyl (4-(dimethoxymethyl)phenyl)carbamate |
475160-88-4 |
C24H23NO4 |
 |
Posaconazole Impurity 18 |
213381-06-7 |
C37H42F2N8O4 |
![2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile](/CAS/20180531/GIF/1187594-13-3.gif) |
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile |
1187594-13-3 |
C22H31N7O3SSi |
 |
Δ3-Flomoxef sodium |
|
|
 |
Derivatives intermediate 3 |
1213710-50-9 |
C21H30N2O |
 |
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
 |
5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide |
31127-80-7 |
C16H20I3N3O7 |
 |
ETHYL 3-BUTENOATE |
1617-18-1 |
C6H10O2 |
 |
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
 |
9-OXO-11ALPHA-15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
34210-10-1 |
C20H28D4O5 |
 |
5-(4-Hydroxyphenyl)-2,4-imidazolidinedione |
2420-17-9 |
C9H8N2O3 |
 |
2-Azepan-1-yl-ethylamine |
51388-00-2 |
C8H18N2 |
 |
4,7-DIHYDROXYCOUMARIN |
1983-81-9 |
C9H6O4 |
 |
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
 |
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
 |
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
118864-75-8 |
C15H15N |
 |
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
![4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol](/CAS/20180808/GIF/20051-76-7.gif) |
4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol |
20051-76-7 |
C20H27NO3 |
 |
Carbamazepine intermediate |
|
|
 |
(6R,7S)-Ceftriaxone Epimer |
|
|
 |
Triphenylsulfonium chloride |
4270-70-6 |
C18H15ClS |
 |
5-GERANOXY-7-METHOXYCOUMARIN |
7380-39-4 |
C20H24O4 |
 |
ACETIC ACID 2-PHENOXYETHYL ESTER |
6192-44-5 |
C10H12O3 |
 |
ETHYL 1-HYDROXYCYCLOPENTANE-CARBOXYLATE |
41248-23-1 |
C8H14O3 |
 |
Danshen injection intermediate |
|
|
 |
Azacitidine Isomer |
|
|
 |
6-FLUORO-4-HYDROXYCOUMARIN |
1994-13-4 |
C9H5FO3 |
 |
Cefazolin Related Compound D |
|
|
 |
Sugammadex sodium hexabromide intermediate |
|
|
 |
(3S,5R,2R,3S)-posaconazole |
|
|
 |
2',3',5'-TRI-O-BENZOYLINOSINE |
6741-88-4 |
C31H24N4O8 |
 |
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |